Nick Corriveau-Lecavalier
Overview
Explore the profile of Nick Corriveau-Lecavalier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sintini I, Corriveau-Lecavalier N, Jones D, Machulda M, Gunter J, Schwarz C, et al.
Brain Commun
. 2024 Mar;
6(2):fcae005.
PMID: 38444909
Disruption of the default mode network is a hallmark of Alzheimer's disease, which has not been extensively examined in atypical phenotypes. We investigated cross-sectional and 1-year longitudinal changes in default...
12.
Decarie-Labbe L, Dialahy I, Corriveau-Lecavalier N, Mellah S, Belleville S
Cortex
. 2024 Mar;
173:234-247.
PMID: 38432175
Previous studies have reported a pattern of hyperactivation in the pre-dementia phase of Alzheimer's disease (AD), followed by hypoactivation in later stages of the disease. This pattern was modeled as...
13.
Corriveau-Lecavalier N, Barnard L, Przybelski S, Gogineni V, Botha H, Graff-Radford J, et al.
Neuroimage Clin
. 2023 Dec;
41:103559.
PMID: 38147792
Genetic mutations causative of frontotemporal lobar degeneration (FTLD) are highly predictive of a specific proteinopathy, but there exists substantial inter-individual variability in their patterns of network degeneration and clinical manifestations....
14.
Corriveau-Lecavalier N, Tosakulwong N, Lesnick T, Fought A, Reid R, Schwarz C, et al.
Neurobiol Aging
. 2023 Dec;
134:135-145.
PMID: 38091751
We assessed white matter (WM) integrity in MAPT mutation carriers (16 asymptomatic, 5 symptomatic) compared to 31 non-carrier family controls using diffusion tensor imaging (DTI) (fractional anisotropy; FA, mean diffusivity;...
15.
Corriveau-Lecavalier N, Botha H, Graff-Radford J, Switzer A, Przybelski S, Wiste H, et al.
medRxiv
. 2023 Dec;
PMID: 38045300
Limbic-predominant age-related TDP-43 encephalopathy (LATE) is a neuropathologically-defined disease that affects 40% of persons in advanced age, but its associated neurological syndrome is not defined. LATE neuropathological changes (LATE-NC) are...
16.
Corriveau-Lecavalier N, Barnard L, Botha H, Graff-Radford J, Ramanan V, Lee J, et al.
Brain
. 2023 Oct;
147(4):1483-1496.
PMID: 37831661
There is a longstanding ambiguity regarding the clinical diagnosis of dementia syndromes predominantly targeting executive functions versus behaviour and personality. This is due to an incomplete understanding of the macro-scale...
17.
Lee J, Burkett B, Min H, Senjem M, Dicks E, Corriveau-Lecavalier N, et al.
Brain
. 2023 Oct;
147(3):980-995.
PMID: 37804318
Given the prevalence of dementia and the development of pathology-specific disease-modifying therapies, high-value biomarker strategies to inform medical decision-making are critical. In vivo tau-PET is an ideal target as a...
18.
Vogel J, Corriveau-Lecavalier N, Franzmeier N, Pereira J, Brown J, Maass A, et al.
Nat Rev Neurosci
. 2023 Aug;
24(10):620-639.
PMID: 37620599
Neurodegenerative diseases are the most common cause of dementia. Although their underlying molecular pathologies have been identified, there is substantial heterogeneity in the patterns of progressive brain alterations across and...
19.
Corriveau-Lecavalier N, Gunter J, Kamykowski M, Dicks E, Botha H, Kremers W, et al.
Brain Commun
. 2023 Apr;
5(2):fcad058.
PMID: 37013176
From a complex systems perspective, clinical syndromes emerging from neurodegenerative diseases are thought to result from multiscale interactions between aggregates of misfolded proteins and the disequilibrium of large-scale networks coordinating...
20.
Corriveau-Lecavalier N, Barnard L, Lee J, Dicks E, Botha H, Graff-Radford J, et al.
Cereb Cortex
. 2023 Feb;
33(11):7026-7043.
PMID: 36721911
Dysexecutive Alzheimer's disease (dAD) manifests as a progressive dysexecutive syndrome without prominent behavioral features, and previous studies suggest clinico-radiological heterogeneity within this syndrome. We uncovered this heterogeneity using unsupervised machine...